|

Feasibility Trial of Combination of Obstetrical Carrier Screening and Hereditary Cancer Screening

RECRUITINGN/ASponsored by Columbia University
Actively Recruiting
PhaseN/A
SponsorColumbia University
Started2026-02-12
Est. completion2027-12-31
Eligibility
Age18 Years – 55 Years
SexFEMALE
Healthy vol.Accepted
Locations1 site

Summary

The investigators hypothesize that preconception and pregnancy may be a feasible and effective time to offer inherited cancer risk screening. This study will assess interest in cancer genetic testing among patients receiving routine prenatal care or preconception care. The goal is to evaluate the acceptability of hereditary cancer testing when offered alongside standard prenatal genetic screening. The study will also explore whether universal screening in this population could support early cancer prevention

Eligibility

Age: 18 Years – 55 YearsSex: FEMALEHealthy volunteers accepted
Inclusion criteria:

* Age: 18 years - 55 years
* Patients receiving obstetrical-related care at a CUMC-affiliated enrollment site
* Patients who have elected to undergo OCS with the CUMC-affiliated obstetrics provider
* Patients with prior OCS but planned to repeat OCS are eligible
* Patients can speak and read in English or Spanish

Exclusion criteria:

* Patients who have previously completed a multigene hereditary cancer syndrome panel
* Patients that have a hematologic cancer or hematologic pre-cancer
* Patients who have a history of an autologous bone marrow transplant

Conditions2

CancerHereditary Cancer Syndrome

Locations1 site

Columbia University Irving Medical Center
New York, New York, 10032
Jessica Giordano212-305-7250jlg2197@cumc.columbia.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.